| Literature DB >> 20628386 |
H K Amarasinghe1, N W Johnson, R Lalloo, M Kumaraarachchi, S Warnakulasuriya.
Abstract
BACKGROUND: Oral and pharyngeal cancers constitute the sixth most common type of cancer globally, with high morbidity and mortality. In many countries, most cases of oral cancer arise from long-standing, pre-existing lesions, yet advanced malignancies prevail. A new approach to early detection is needed. We aimed to validate a model for screening so that only high-risk individuals receive the clinical examination.Entities:
Mesh:
Year: 2010 PMID: 20628386 PMCID: PMC2920027 DOI: 10.1038/sj.bjc.6605778
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640
Association between OPMD and sociodemographic indicators, habits and nutritional factors in Phase 1 study
|
|
|
|
| |
|---|---|---|---|---|
|
| ||||
| Female | 33 (32.7) | 495 (68.0) | 1.0 | 1.0 |
| Male | 68 (67.3) | 233 (32.0) | 4.4 (2.8–6.8) | 2.1 (1.0–4.4) |
|
| ||||
| 30–39 | 21 (9.8) | 194 (90.2) | 1.0 | 1.0 |
| 40–49 | 28 (13.2) | 184 (86.8) | 1.4 (0.8–2.5) | 1.1 (0.5–2.3) |
| 50–59 | 33 (17.2) | 159 (82.8) | 1.9 (1.06–3.4) | 1.0 (0.5–2.1) |
| ⩽60 | 19 (9.0) | 191 (91.0) | 0.9 (0.5–1.7) | 0.5 (0.2–1.1) |
|
| ||||
| High | 3 (3.0) | 98 (97.0) | 1.0 | 1.0 |
| Middle | 22 (9.6) | 206 (90.4) | 3.5 (1.0–11.9) | 3.3 (0.7–15.6) |
| Low | 76 (15.2) | 424 (84.8) | 5.8 (1.8–18.9) | 3.0 (0.6–14.3) |
| BMI (continuous) | — | — | 0.9 (0.8–0.9) | 0.97 (0.9–1.0) |
| — | — | 0.8 (0.6–0.99) | 1.0 (0.8–1.3) | |
|
| ||||
| Never | 4 (4.0) | 277 (38.0) | 1.0 | 1.0 |
| Past and occasionally | 5 (5.0) | 119 (16.3) | 2.9 (0.7–11.0) | 2.2 (0.6–8.7) |
| Daily | 92 (91.1) | 332 (45.6) | 19.2 (6.9–52.9) | 10.1 (3.4–29.7) |
|
| ||||
| No chewing | 4 (1.4) | 277 (98.6) | 1.0 | 1.0 |
| ⩽3 | 7 (5.3) | 125 (94.7) | 3.5 (1.1–11.3) | 2.5 (0.7–8.7) |
| >3 | 85 (29.1) | 207 (70.9) | 27.3 (9.9–75.6) | 16.2 (5.3–48.7) |
|
| ||||
| No drinking | 39 (38.6) | 551 (75.7) | 1.0 | 1.0 |
| Past, occasional | 27 (19.1) | 114 (80.9) | 3.3 (1.9–5.7) | 1.1 (0.5–2.6) |
| Monthly, weekly and daily | 35 (35.7) | 63 (64.3) | 7.8 (4.6–13.3) | 2.7 (1.2–6.3) |
|
| ||||
| Never | 66 (65.3) | 601 (82.6) | 1.0 | 1.0 |
| Ever | 35 (34.7) | 127 (17.4) | 2.4 (1.6–3.9) | 1.0 (0.5–1.7) |
| Total | 101 (100) | 728 (100) | ||
Abbreviations: BMI=body mass index; CI=confidence interval; OPMD=oral potentially malignant disorder; OR=odds ratio.
OR adjusted for sex, age, socioeconomic status, β-carotene-containing fruits and vegetable portion, BMI, smoking, betel chewing and alcohol drinking.
The sum does not add to the total because past and occasional chewers were excluded from the analysis.
Risk factor model
|
|
|
|---|---|
|
| |
| 15–30 | 0 |
| >31 | 3 |
|
| |
| High | 0 |
| Middle and low | 3 |
|
| |
| Never | 0 |
| 0–3 | 2.5 |
| >3 | 16 |
|
| |
| Never | 0 |
| Past, occasional | 1 |
| Daily or at least weekly | 3 |
|
| |
| Never | 0 |
| Ever | 1 |
Figure 1(A) The ROC curve for risk-factor model score and the presence of OPMD (except lichen planus) in Phase 1 study. (B) The ROC curve for risk-factor model score and the presence of all oral mucosal disorders in Phase 1 study.
Frequency distribution of cases and controls, applying a 12 cutoff point for the combined score and the presence of OPMD, excluding lichen planus in Phase 1 study
|
|
|
|
|
|---|---|---|---|
| Disease – above 12 | 89 | 235 | 324 |
| No disease – <12 | 6 | 493 | 499 |
| Total | 95 | 728 | 823 |
Abbreviation: OPMD=oral potentially malignant disorder.
Frequency distribution of cases and controls, applying a 12 cutoff point for the combined score and the presence of all oral mucosal diseases in Phase 1 study
|
|
|
|
|
|---|---|---|---|
| Disease – above 12 | 244 | 235 | 479 |
| No disease – <12 | 57 | 493 | 550 |
| Total | 301 | 728 | 1029 |
Figure 2(A) The ROC curve for risk-factor model score and the presence of OPMD (except lichen planus) in Phase 2 validation study. (B) The ROC curve for risk-factor model score and the presence of all oral mucosal disorders in Phase 2 validation study.
Frequency distribution of cases and controls, applying a 12 cutoff point for the combined score and the presence of OPMD, excluding lichen planus in Phase 2 study
|
|
|
|
|
|---|---|---|---|
| Disease – above 12 | 42 | 75 | 117 |
| No disease – <12 | 2 | 237 | 239 |
| Total | 44 | 312 | 356 |
Abbreviation: OPMD=oral potentially malignant disorder.
Frequency distribution of cases and controls, applying a 12 cutoff point for the combined score and the presence of all oral mucosal disorders in Phase 2 study
|
|
|
|
|
|---|---|---|---|
| Disease – above 12 | 81 | 75 | 156 |
| No disease – <12 | 14 | 237 | 251 |
| Total | 95 | 312 | 407 |
Sensitivity and specificity of proposed model for screening compared with test outcomes for other major cancers
|
|
|
|
|---|---|---|
| OPMD using risk-factor model – Phase 1 | 93.7 | 67.7 |
| OPMD using risk-factor model – Phase 2 | 95.5 | 75.9 |
| Breast cancer screening using mammography | 75–90 | 90–95 |
| Cervical cancer screening using PAP test | 50–85 | 95–99 |
| Colorectal cancer screening with faecal occult blood test | 66–85 | 95–97 |
Abbreviation: OPMD=oral potentially malignant disorder.